IRIS
TERRANOVA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.137
NA - Nord America 1.041
EU - Europa 442
SA - Sud America 241
AF - Africa 25
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.894
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.154
US - Stati Uniti d'America 968
CN - Cina 466
HK - Hong Kong 313
BR - Brasile 179
IT - Italia 133
VN - Vietnam 116
GB - Regno Unito 110
DE - Germania 70
CA - Canada 42
AR - Argentina 27
MX - Messico 21
NL - Olanda 20
IN - India 19
CZ - Repubblica Ceca 18
JP - Giappone 16
FR - Francia 14
ZA - Sudafrica 11
CL - Cile 9
EE - Estonia 9
FI - Finlandia 9
TR - Turchia 9
ES - Italia 8
ID - Indonesia 8
BD - Bangladesh 7
PL - Polonia 7
SE - Svezia 7
AU - Australia 6
EC - Ecuador 6
RU - Federazione Russa 6
UY - Uruguay 5
AT - Austria 4
CO - Colombia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IQ - Iraq 4
TW - Taiwan 4
UA - Ucraina 4
KR - Corea 3
NO - Norvegia 3
PE - Perù 3
PY - Paraguay 3
RS - Serbia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CH - Svizzera 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CU - Cuba 1
DZ - Algeria 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.894
Salva come PNG Salva come JPEG
Città #
Singapore 329
Hong Kong 305
Ashburn 281
Hefei 212
Boardman 116
Beijing 87
London 86
Shanghai 68
Rome 66
Santa Clara 66
Ho Chi Minh City 41
Los Angeles 37
San Francisco 35
Munich 33
Dallas 27
São Paulo 23
Washington 21
Buffalo 20
Montreal 20
Brno 18
Council Bluffs 18
Hanoi 16
Toronto 16
Amsterdam 14
Tokyo 14
Seattle 13
Secaucus 12
Brooklyn 10
Chicago 10
New York 10
Pune 10
Grumo Nevano 9
Johannesburg 9
Boston 8
Milan 8
Paris 8
Rio de Janeiro 8
Da Nang 7
Mexico City 7
Coral Springs 6
Haiphong 6
Warsaw 6
Naples 5
Phoenix 5
Santiago 5
Stockholm 5
Temecula 5
Thái Bình 5
Biên Hòa 4
Buenos Aires 4
Canberra 4
Catania 4
Cuautitlán Izcalli 4
Helsinki 4
Taipei 4
The Dalles 4
Turku 4
Ankara 3
Anápolis 3
Charlotte 3
Cleveland 3
Cusano Milanino 3
Duque de Caxias 3
Guangzhou 3
Guayaquil 3
Hải Dương 3
Las Vegas 3
Lima 3
Louisville 3
Manaus 3
Medellín 3
Montevideo 3
Mysore 3
Newark 3
Ninh Bình 3
Nuremberg 3
Quận Bình Thạnh 3
Ribeirão Preto 3
Salvador 3
Seoul 3
Sonoma 3
Vĩnh Tường 3
Zhengzhou 3
Alexandria 2
Baghdad 2
Banhā 2
Belo Horizonte 2
Belém 2
Brasília 2
Brusaporto 2
Buford 2
Calgary 2
Cape Town 2
Chennai 2
Columbia 2
Cotia 2
Del Viso 2
Edinburgh 2
Elk Grove Village 2
Faella 2
Totale 2.294
Salva come PNG Salva come JPEG
Nome #
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 222
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 215
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies 214
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 214
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 208
The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study 208
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 207
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 204
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 203
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 200
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 200
Analysis of ultrasonographic and hystopathologic features of placental invasiveness in Vitro Fertilization (IVF) pregnancies: a prospective study 197
Human embryo: what about relatedness? 195
Does HE4 have a role in the recurrence of ovarian cancer? 188
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 188
Intraoperative contact ultrasonography during open myomectomy for uterine fibroids 187
Chronic subtorsion of the ovary with subsequent ovarian hypoplasia 186
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study 183
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 175
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 170
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 168
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 112
A critical review on HE4 performance in endometrial cancer: where are we now? 112
A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection 105
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 104
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 99
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 96
A new type of absorbable barbed suture for use in laparoscopic myomectomy 95
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 94
Assessing HPV vaccination perceptions with online social media in Italy 94
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 94
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 94
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 92
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 91
[The role of laparoscopy in ovarian carcinoma]. 90
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 89
Chirurgia Benigna 89
Economic impact among family caregivers of patients with advanced ovarian cancer 89
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study 84
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 83
The Rendezvous Technique: A Minimally Invasive Non-Surgical Approach for the Management of Iatrogenic Ureteral Injuries 53
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 49
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 47
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 46
Miomectomia laparoscopica: fattibilità e learning curve 45
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 43
Studio prospettico randomizzato comparativo tra due tecniche 42
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 42
The role of ovarian fossa evaluation in patients with ovarian endometriosis 40
PREOPERATIVE LOCAL STAGING OF ENDOMETRIAL CANCER: THE CHALLENGE OF IMAGING TECHNIQUES AND SERUM BIOMARKERS 40
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers 40
Laparoscopic myomectomy learning curve safety and feasibility. 40
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 39
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 37
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 37
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 37
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 37
Ovarian cancer relapse: From the latest scientific evidence to the best practice 36
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 36
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 36
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 36
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 32
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 32
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 32
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 30
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 30
Ten years of HPV vaccines: State of art and controversies 30
Real-time infrared thermography for ureter detection during hysterectomy 30
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial 30
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 29
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 28
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test 27
The endogenous oxytocin after manipulative osteopathic treatment in full-term pregnant women 27
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 27
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program 27
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 27
The role of macroplastique implantation in the management of occult urinary stress incontinence 27
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature 26
Over-the-counter emergency contraception in Italy: ethical reflections and medico-legal issues 26
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 26
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 26
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. 26
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix 25
Dual HER2/PIK3CA targeting overcomes single-agent acquired resistance in HER2-amplified uterine serous carcinoma cell lines in vitro and in vivo 25
The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study 25
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 25
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 24
Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature 24
Hormone replacement therapy in cancer survivors: Utopia? 24
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 24
TOTAL RECTOSIGMOIDECTOMY VERSUS PARTIAL RECTAL RESECTION IN ADVANCED OVARIAN CANCER SURGICAL DEBULKING: A CASE CONTROL STUDY 24
RANDOMIZED CONTROL TRIAL COMPARING FOUR VERSUS SIX COURSES OF ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PREVIOUSLY TREATED WITH NEO-ADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY 24
The Role of Novel Serum Biomarker HE4 in Endometrial Cancer 23
NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER 23
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 23
ROBOTIC PELVIC LYMPHADENECTOMY: STEPS AND TECHNIQUE 23
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 22
Studio prospettico randomizzato comparativo tra due tecniche chirurgiche per il trattamento dell’incontinenza urinaria da sforzo: accesso retropubico vs transotturatorio 21
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 21
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis 20
Totale 7.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 3 1 0 0 1 4 4 3 0 122
2022/202351 0 0 1 2 1 1 12 2 3 3 17 9
2023/2024491 10 42 46 43 43 147 4 64 9 20 30 33
2024/20255.876 107 25 122 33 27 98 83 65 276 341 2.288 2.411
2025/20261.388 313 168 182 399 202 124 0 0 0 0 0 0
Totale 7.944